Abstract B88: A selective Raf kinase inhibitor induces cell death and tumor regression of human cancer cell lines encoding B‐RafV600Emutation

Author(s):  
Sylvie Laquerre ◽  
Marc Arnone ◽  
Katherine Moss ◽  
Jingsong Yang ◽  
Kelly Fisher ◽  
...  
2012 ◽  
Vol 28 (4) ◽  
pp. 201-212 ◽  
Author(s):  
Eystein Oveland ◽  
Line Wergeland ◽  
Randi Hovland ◽  
James B. Lorens ◽  
Bjørn Tore Gjertsen ◽  
...  

2018 ◽  
Vol 32 (S1) ◽  
Author(s):  
David Kelly Strom ◽  
Dalon Li ◽  
Hanna Brinkman ◽  
Stephanie Gleason ◽  
Sarah Hershberger ◽  
...  

2016 ◽  
Vol 241 (18) ◽  
pp. 2015-2022 ◽  
Author(s):  
Mohamed El-Mesery ◽  
Mohamed E Shaker ◽  
Abdelaziz Elgaml

The inhibitors of apoptosis proteins are implicated in promoting cancer cells survival and resistance toward immune surveillance and chemotherapy. Second mitochondria-derived activator of caspases (SMAC) mimetics are novel compounds developed to mimic the inhibitory effect of the endogenous SMAC/DIABLO on these IAPs. Here, we examined the potential effects of the novel SMAC mimetic BV6 on different human cancer cell lines. Our results indicated that BV6 was able to induce cell death in different human cancer cell lines. Mechanistically, BV6 dose dependently induced degradation of IAPs, including cIAP1 and cIAP2. This was coincided with activating the non-canonical NF -kappa B (NF-κB) pathway, as indicated by stabilizing NF-κB-inducing kinase (NIK) for p100 processing to p52. More interestingly, BV6 was able to sensitize some of the resistant cancer cell lines to apoptosis induced by the death ligands tumor necrosis factor-α (TNF-α) and TNF-related apoptosis-inducing ligand (TRAIL) that are produced by different cells of the immune system. Such cell death enhancement was mediated by inducing an additional cleavage of caspase-9 to augment that of caspase-8 induced by death ligands. This eventually led to more processing of the executioner caspase-3 and poly (ADP-ribose) polymerase (PARP). In conclusion, therapeutic targeting of IAPs by BV6 might be an effective approach to enhance cancer regression induced by immune system. Our data also open up the future possibility of using BV6 in combination with other antitumor therapies to overcome cancer drug resistance.


2015 ◽  
Vol 8 (10) ◽  
pp. 798-806 ◽  
Author(s):  
Alice Abreu Ramos ◽  
Maria Prata-Sena ◽  
Bruno Castro-Carvalho ◽  
Tida Dethoup ◽  
Suradet Buttachon ◽  
...  

PLoS ONE ◽  
2014 ◽  
Vol 9 (7) ◽  
pp. e101220 ◽  
Author(s):  
Clementina Sansone ◽  
Alessandra Braca ◽  
Elena Ercolesi ◽  
Giovanna Romano ◽  
Anna Palumbo ◽  
...  

Planta Medica ◽  
2021 ◽  
Author(s):  
Allison Ledoux ◽  
Daphnée Bériot ◽  
Lucia Mamede ◽  
Pauline Desdemoustier ◽  
Fanny Detroz ◽  
...  

Abstract Poupartia borbonica is an endemic tree from the Mascarene Islands that belongs to the Anacardiaceae family. The leaves of this plant were phytochemically studied previously, and isolated alkyl cyclohexenone derivatives, poupartones A – C, demonstrated antiplasmodial and antimalarial activities. In addition to their high potency against the Plasmodium sp., high toxicity on human cells was also displayed. The present study aims to investigate in more detail the cytotoxicity and pharmacological interest of poupartone B, one of the most abundant derivatives in the leaves of P. borbonica. For that purpose, real-time live-cell imaging of different human cancer cell lines and normal fibroblasts, treated or not treated with poupartone B, was performed. A potent inhibition of cell proliferation associated with the induction of cell death was observed. A detailed morphological analysis of different adherent cell lines exposed to high concentrations of poupartone B (1 – 2 µg/mL) demonstrated that this compound induced an array of cellular alterations, including a rapid retraction of cellular protrusions associated with cell rounding, massive cytoplasmic vacuolization, loss of plasma membrane integrity, and plasma membrane bubbling, ultimately leading to paraptosis-like cell death. The structure-activity relation of this class of compounds, their selective toxicity, and pharmacological potential are discussed.


Sign in / Sign up

Export Citation Format

Share Document